Jacques E. Rossouw

42.8k total citations · 8 hit papers
149 papers, 22.1k citations indexed

About

Jacques E. Rossouw is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jacques E. Rossouw has authored 149 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 58 papers in Genetics and 37 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jacques E. Rossouw's work include Menopause: Health Impacts and Treatments (60 papers), Estrogen and related hormone effects (52 papers) and Lipoproteins and Cardiovascular Health (16 papers). Jacques E. Rossouw is often cited by papers focused on Menopause: Health Impacts and Treatments (60 papers), Estrogen and related hormone effects (52 papers) and Lipoproteins and Cardiovascular Health (16 papers). Jacques E. Rossouw collaborates with scholars based in United States, South Africa and United Kingdom. Jacques E. Rossouw's co-authors include JoAnn E. Manson, Ross L. Prentice, Karen L. Margolis, Karen Johnson, Marcia L. Stefanick, Garnet L. Anderson, Andrea Z. LaCroix, Mary Pettinger, Marian C. Limacher and Judith Hsia and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Jacques E. Rossouw

145 papers receiving 21.0k citations

Hit Papers

Risks and Benefits of Estrogen Plus Progestin in Healthy ... 2002 2026 2010 2018 2002 2003 2007 2003 2003 2.5k 5.0k 7.5k 10.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
    2002 11.2k citations Jacques E. Rossouw profile →
  2. Estrogen plus Progestin and the Risk of Coronary Heart Disease
    2003 1.4k citations JoAnn E. Manson, Karen Johnson et al. profile →
  3. Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
    2007 1.2k citations Jacques E. Rossouw, Ross L. Prentice et al. profile →
  4. Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women
    2003 827 citations Sylvia Wassertheil‐Smoller, Marian C. Limacher et al. profile →
  5. The women's health initiative recruitment methods and results
    2003 604 citations Garnet L. Anderson, Marian C. Limacher et al. profile →
  6. Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease
    2002 543 citations JoAnn E. Manson, Jacques E. Rossouw et al. profile →
  7. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
    2017 344 citations JoAnn E. Manson, Aaron K. Aragaki et al. profile →
  8. The Women’s Health Initiative Randomized Trials and Clinical Practice
    2024 45 citations JoAnn E. Manson, Jacques E. Rossouw et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques E. Rossouw United States 45 10.6k 9.7k 4.3k 3.9k 3.1k 149 22.1k
Karen Johnson United States 60 4.7k 0.4× 4.0k 0.4× 2.8k 0.7× 2.9k 0.8× 3.8k 1.2× 332 17.9k
Deborah Grady United States 57 5.6k 0.5× 5.4k 0.6× 1.9k 0.4× 2.5k 0.6× 1.2k 0.4× 150 14.7k
Yvonne T. van der Schouw Netherlands 79 6.8k 0.6× 3.4k 0.4× 3.1k 0.7× 1.4k 0.4× 4.9k 1.6× 473 23.2k
Susan E. Hankinson United States 95 6.6k 0.6× 7.3k 0.8× 3.9k 0.9× 11.1k 2.9× 6.1k 2.0× 468 35.1k
Rowan T. Chlebowski United States 79 4.0k 0.4× 7.7k 0.8× 3.1k 0.7× 13.3k 3.4× 3.2k 1.0× 454 24.9k
Bruce Ettinger United States 64 5.6k 0.5× 5.3k 0.5× 2.9k 0.7× 4.6k 1.2× 1.1k 0.4× 209 17.5k
Anne McTiernan United States 95 3.3k 0.3× 4.9k 0.5× 2.4k 0.6× 15.3k 3.9× 5.2k 1.7× 380 32.4k
Charles L. Loprinzi United States 91 4.5k 0.4× 4.2k 0.4× 3.9k 0.9× 15.5k 4.0× 2.2k 0.7× 531 33.3k
Howard N. Hodis United States 69 8.2k 0.8× 3.8k 0.4× 2.0k 0.5× 807 0.2× 1.5k 0.5× 279 19.4k
Laurence N. Kolonel United States 90 3.1k 0.3× 5.8k 0.6× 4.1k 0.9× 8.4k 2.2× 6.9k 2.2× 435 28.6k

Countries citing papers authored by Jacques E. Rossouw

Since Specialization
Citations

This map shows the geographic impact of Jacques E. Rossouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques E. Rossouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques E. Rossouw more than expected).

Fields of papers citing papers by Jacques E. Rossouw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques E. Rossouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques E. Rossouw. The network helps show where Jacques E. Rossouw may publish in the future.

Co-authorship network of co-authors of Jacques E. Rossouw

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques E. Rossouw. A scholar is included among the top collaborators of Jacques E. Rossouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques E. Rossouw. Jacques E. Rossouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, John W., Aaron K. Aragaki, Laura B. Harrington, et al.. (2025). Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women’s Health Initiative trial. Menopause The Journal of The North American Menopause Society. 33(2). 134–144.
2.
Nudy, Matthew, Aaron K. Aragaki, Xuezhi Jiang, et al.. (2025). Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials. Obstetrics and Gynecology. 145(4). 357–367. 4 indexed citations
3.
Prentice, Ross L., Barbara V. Howard, Linda Van Horn, et al.. (2021). Nutritional epidemiology and the Women’s Health Initiative: a review. American Journal of Clinical Nutrition. 113(5). 1083–1092. 10 indexed citations
4.
Prentice, Ross L., Aaron K. Aragaki, Barbara V. Howard, et al.. (2019). Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes. Journal of Nutrition. 149(9). 1565–1574. 37 indexed citations
5.
Manson, JoAnn E., Aaron K. Aragaki, Jacques E. Rossouw, et al.. (2018). Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. Obstetrical & Gynecological Survey. 73(1). 22–24. 31 indexed citations
6.
Liu, Qing, Jacques E. Rossouw, Mary B. Roberts, et al.. (2016). Theoretical Effects of Substituting Butter with Margarine on Risk of Cardiovascular Disease. Epidemiology. 28(1). 145–156. 17 indexed citations
7.
Haring, Bernhard, Chunyuan Wu, Laura H. Coker, et al.. (2015). Abstract 50: Hypertension, Antihypertensive Treatment, Sodium Intake and Cognitive Decline. Circulation. 131. 1 indexed citations
8.
Luo, Juhua, Jacques E. Rossouw, E. Tong, et al.. (2013). Smoking and Diabetes: Does the Increased Risk Ever Go Away?. American Journal of Epidemiology. 178(6). 937–945. 53 indexed citations
9.
Rossouw, Jacques E., JoAnn E. Manson, Andrew M. Kaunitz, & Garnet L. Anderson. (2013). Lessons Learned From the Women's Health Initiative Trials of Menopausal Hormone Therapy. Obstetrics and Gynecology. 121(1). 172–176. 78 indexed citations
10.
Kim, Hyeon Chang, Philip Greenland, Jacques E. Rossouw, et al.. (2010). Multimarker Prediction of Coronary Heart Disease Risk. Journal of the American College of Cardiology. 55(19). 2080–2091. 85 indexed citations
11.
Heiss, Gerardo, Robert L. Wallace, Garnet L. Anderson, et al.. (2008). Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. Obstetrical & Gynecological Survey. 63(7). 440–442.
12.
Rossouw, Jacques E., Ross L. Prentice, JoAnn E. Manson, et al.. (2007). Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause. Obstetrical & Gynecological Survey. 62(8). 522–523. 98 indexed citations
13.
Rossouw, Jacques E.. (2001). Early risk of cardiovascular events after commencing hormone replacement therapy. Current Opinion in Lipidology. 12(4). 371–375. 14 indexed citations
14.
Rossouw, Jacques E.. (1999). Does Estrogen Have a Role in the Prevention of Cardiovascular Disease?. The Journal of Clinical Endocrinology & Metabolism. 84(6). 1806–1812. 3 indexed citations
15.
Steyn, Krisela, Jacques E. Rossouw, M.J. Weight, et al.. (1996). Apolipoprotein B levels and related factors in a rural white South African community - the CORIS study. 86(4). 359–364. 1 indexed citations
16.
17.
Jooste, P. L., et al.. (1991). Changes in smoking during a community-based cardiovascular disease intervention programme. The Coronary Risk Factor Study.. PubMed. 79(5). 250–3. 10 indexed citations
18.
Rossouw, Jacques E., P. L. Jooste, Krisela Steyn, & A. J. S. Benadé. (1985). Serum total and high-density lipoprotein cholesterol--reference values obtained in the Coronary Risk Factor Study baseline survey.. PubMed. 67(14). 533–8. 20 indexed citations
19.
Przybojewski, J. Z., et al.. (1983). Rupture of sinus of Valsalva aneurysm into both right atrium and right ventricle. South African Medical Journal. 68(16). 616–625. 4 indexed citations
20.
Rossouw, Jacques E., et al.. (1978). Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(12). 436–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Johnson Breakdown of academic impact, for papers by Deborah Grady Breakdown of academic impact, for papers by Yvonne T. van der Schouw Breakdown of academic impact, for papers by Susan E. Hankinson Breakdown of academic impact, for papers by Rowan T. Chlebowski Breakdown of academic impact, for papers by Bruce Ettinger Breakdown of academic impact, for papers by Anne McTiernan Breakdown of academic impact, for papers by Charles L. Loprinzi Breakdown of academic impact, for papers by Howard N. Hodis Breakdown of academic impact, for papers by Laurence N. Kolonel
Rankless by CCL
2026